Top news

View all

Global deployment of rapid diagnostic tests to boost fight against cholera

More than 1.2 million cholera rapid diagnostic tests will be shipped to 14 countries in largest-ever global deployment, with the first shipment landing today in Malawi.

Gavi increases support to reach all children with immunisation in the Central African Republic

Gavi to increase its financial support to strengthen data systems, bolster health workforce and engagement at community level, and foster innovation for enhancing outreach to better identify and reach missed children.

France to co-host with African Union and Gavi the launch of the African Vaccine Manufacturing Accelerator (AVMA) and Gavi’s Investment Opportunity for 2026–2030

The high-level event, co-hosted in Paris on 20 June 2024 by the Government of France, the African Union and Gavi, together with Team Europe partners, will gather leaders from government, partner organisations, civil society and business across…

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Visit page

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Visit page

Top VaccinesWork stories

View all stories

In Pakistan, risk of snakebites mounts amid floods

Climate change could make the danger from venomous snakes worse and less predictable, experts warn.

After measles, a life in the dark

Not so long ago, measles was the leading cause of childhood blindness in poor countries. Vaccination and vitamin A supplementation helped – but now measles cases are again on the rise. In Ethiopia, VaccinesWork spoke to sightless survivors.

Vaccines support

Gavi supports vaccines against 19 infectious diseases, including, most recently, COVID-19, Ebola and malaria. Learn more about our support for each vaccine by clicking below.

Visit page

Gavi supports vaccines against 19 infectious diseases, including, most recently, COVID-19, Ebola and malaria. Learn more about our support for each vaccine by clicking below.

Visit page

Our impact

Children >1 billion children vaccinated through routine programmes
First aid locator >17.3 million future deaths averted
Transitioned 19 countries fully self-financing
Billions >220.5 US$ billion in economic benefits for countries
Syringe 1.8 billion vaccinations through preventive vaccination campaigns

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Visit page

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Visit page

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter